We are live on ! Find out more
HPC

HM Payson & Co Portfolio holdings

AUM $7.54B
1-Year Est. Return 31.34%
This Fund
S&P 500
This Quarter Est. Return
+5.44%
1 Year Est. Return
+31.34%
3 Year Est. Return
+94.39%
5 Year Est. Return
+124.39%
10 Year Est. Return
+419.98%
AUM
$4.17B
AUM Growth
+$154M
Cap. Flow
+$10.7M
Cap. Flow %
0.26%
Top 10 Hldgs %
32.44%
Holding
1,048
New
115
Increased
124
Reduced
320
Closed
26

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$47.3M
2
NXPI icon
NXP Semiconductors
NXPI
+$22.9M
3
DVY icon
iShares Select Dividend ETF
DVY
+$9.57M
4
PFE icon
Pfizer
PFE
+$9.55M
5
HPQ icon
HP
HPQ
+$4.55M

Sector Composition

Rank Sector Weight
1 Technology 27.09%
2 Healthcare 19.4%
3 Financials 12.34%
4 Industrials 9.97%
5 Consumer Discretionary 9.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DHR icon
26
Danaher
DHR
$135B
$56.8M 1.36%
254,285
+1,593
+0.6% +$362K
AMZN icon
27
Amazon
AMZN
$2.5T
$55.7M 1.33%
538,886
-33,403
-6% -$3.23M
BSCO
28
DELISTED
Invesco BulletShares 2024 Corporate Bond ETF
BSCO
$51.3M 1.23%
2,491,234
+98,894
+4% +$2.03M
HPQ icon
29
HP
HPQ
$23.7B
$51.2M 1.23%
1,744,497
-158,328
-8% -$4.55M
SPGI icon
30
S&P Global
SPGI
$126B
$48.3M 1.16%
140,072
+2,679
+2% +$943K
TJX icon
31
TJX Companies
TJX
$171B
$45.8M 1.1%
585,090
-5,312
-0.9% -$418K
ABT icon
32
Abbott
ABT
$180B
$44.5M 1.07%
439,299
-475
-0.1% -$50.2K
OTIS icon
33
Otis Worldwide
OTIS
$27.5B
$43.9M 1.05%
520,236
+471,774
+973% +$39M
SPY icon
34
State Street SPDR S&P 500 ETF Trust
SPY
$777B
$38.4M 0.92%
93,642
-5,149
-5% -$2.05M
BSCP
35
DELISTED
Invesco BulletShares 2025 Corporate Bond ETF
BSCP
$37.5M 0.9%
1,846,959
-3,004
-0.2% -$60.7K
JPM icon
36
JPMorgan Chase
JPM
$936B
$37M 0.89%
283,950
-2,433
-0.8% -$333K
PG icon
37
Procter & Gamble
PG
$341B
$36.9M 0.89%
248,390
-1,074
-0.4% -$154K
TSM icon
38
TSMC
TSM
$2.1T
$36.7M 0.88%
394,048
+368,256
+1,428% +$33.1M
XOM icon
39
ExxonMobil
XOM
$651B
$36.6M 0.88%
333,935
-970
-0.3% -$107K
PII icon
40
Polaris
PII
$4.16B
$34.9M 0.84%
315,584
+3,781
+1% +$419K
DHI icon
41
D.R. Horton
DHI
$40.7B
$34.4M 0.82%
351,900
+6,565
+2% +$626K
TXN icon
42
Texas Instruments
TXN
$256B
$33.6M 0.81%
180,544
+1,425
+0.8% +$251K
GD icon
43
General Dynamics
GD
$104B
$32.2M 0.77%
141,036
-2,327
-2% -$538K
CVS icon
44
CVS Health
CVS
$137B
$31.7M 0.76%
427,222
-564,084
-57% -$47.3M
LH icon
45
Labcorp
LH
$24.4B
$30.8M 0.74%
156,471
-17,471
-10% -$3.6M
MRK icon
46
Merck
MRK
$324B
$29.1M 0.7%
273,459
+12,535
+5% +$1.35M
AMGN icon
47
Amgen
AMGN
$203B
$28.9M 0.69%
119,512
+5,751
+5% +$1.41M
AZO icon
48
AutoZone
AZO
$47.9B
$26.4M 0.63%
10,739
+3,159
+42% +$7.7M
HON icon
49
Honeywell
HON
$76.6B
$26.4M 0.63%
146,286
-10,949
-7% -$2.06M
ORCL icon
50
Oracle
ORCL
$335B
$26.3M 0.63%
283,480
-878
-0.3% -$77K

Similar funds

HM Payson & Co's Q1 2023 Portfolio in Review

As of Q1 2023, HM Payson & Co held 1,048 positions worth $4.17B, up 3.8% from $4.02B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

HM Payson & Co's Q1 2023 filing shows 115 new, 124 increased, 320 reduced and 26 closed positions. Its largest new stake was State Street SPDR Portfolio S&P 400 Mid Cap ETF: 165,913 shares worth $7.29M. The largest sale was CVS Health, an estimated $47.3M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.

  • HM Payson & Co's largest Q1 2023 buy was State Street SPDR Portfolio S&P 400 Mid Cap ETF: 165,913 shares worth $7.29M.
  • HM Payson & Co added most to Otis Worldwide in Q1 2023, an estimated $39M increase.
  • HM Payson & Co's biggest Q1 2023 reduction was CVS Health, cutting an estimated $47.3M.
  • HM Payson & Co fully exited SVB Financial Group in Q1 2023, selling an estimated $214K.
  • HM Payson & Co's ten largest holdings make up 32% of its $4.17B portfolio in Q1 2023.
  • HM Payson & Co opened 115 new positions and closed 26 in Q1 2023.
  • HM Payson & Co's portfolio value rose 3.8% quarter-over-quarter to $4.17B.

Based on HM Payson & Co's 13F filing for Q1 2023, filed 18 Apr 2023.